Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
about
Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategiesProton pump inhibitors alter the composition of the gut microbiotaATP4a is required for development and function of the Xenopus mucociliary epidermis - a potential model to study proton pump inhibitor-associated pneumonia.Prescribing efficiency of proton pump inhibitors in China: influence and future directionsEffect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis.Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.Prehospital use of inhaled corticosteroids and point prevalence of pneumonia at the time of hospital admission: secondary analysis of a multicenter cohort study.Prevalence of gastroesophageal reflux in cystic fibrosis and implications for lung disease.Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan.Correlation between proton pump inhibitors and risk of pyogenic liver abscess.Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence.Commentary: The link between community-acquired pneumonia and PPI use.Routine prophylaxis with proton pump inhibitors and post-transplant complications in kidney transplant recipients undergoing early corticosteroid withdrawal.Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill Patients.Initiatives in South Africa to enhance the prescribing of generic proton pump inhibitors: findings and implications.The distressing overuse of gastric acid inhibitors.Proton Pump Inhibitor Use Is Associated With an Increased Frequency of Hospitalization in Patients With Cystic Fibrosis.Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications.Streptococcus agalactiae meningoencephalitis associated with gastroesophageal reflux disease and chronic proton pump inhibitors use, in a 9 month-old infant: a case report.Different transcriptional profiling between senescent and non-senescent human coronary artery endothelial cells (HCAECs) by Omeprazole and Lansoprazole treatment.Risk of dementia in elderly patients with the use of proton pump inhibitors.Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
P2860
Q27026351-380C98A7-4D2C-436F-9436-A4A28EA08C58Q28603378-61071F15-271E-4EBE-B7CB-8548152404A9Q30666695-C8427BAD-86DC-457B-B560-9C6B533B8BA2Q35021173-3190024E-2668-4209-A0D7-5B8A6BBEF72AQ35094592-1D029F81-A45E-41A9-9D47-1AE01E3E0195Q36281192-442454B4-A803-498F-B761-D3720344EAF1Q37706605-C7F1D74A-F062-4B5B-BA49-87DBBDD155F7Q38223170-FDD1319E-0B02-4809-9F31-F1E1D55B9492Q38271282-499E698D-46FF-41D5-93F1-0B636E4261A0Q38645653-C875A483-DD17-4920-BE7D-F7D11E3E8AE3Q38824710-BD5E358A-55BD-4C94-AB04-CFD3739D33D0Q38865456-08A3F5F1-696B-47E6-A9A9-68B3860BC4E7Q40071378-B81D4624-6C0B-4819-815A-47A236DE83C8Q40269025-5A3FD255-6B83-47F3-AEC7-990EC27E34A4Q40744956-8209002F-DDE7-4D16-8446-F84FA5FFE6E7Q40771562-E7E93ACC-DE98-4920-BB33-9DA37F9ACAF2Q41136557-BD9E6C82-AAE0-4FC4-AF5D-E8B3859DD66EQ43526669-0A9435EC-CFAA-4269-8D98-399E1BBC343EQ46894129-5BF63412-F495-4B5F-A85A-0E975F701C98Q47283908-52E9800B-C3C6-4EE5-9953-8180D601A781Q47640167-BBA06075-0918-482A-AA92-41FE0BA378DFQ48105004-E6F9A5FC-4B48-4A61-952B-E16764C67CD8Q48186791-0EB6EFFE-C53B-4517-9C90-ECA0D4F49F11Q51252408-68D86B5F-53DD-4556-95D0-6B2F28153227
P2860
Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Proton pump inhibitor therapy ...... tococcus pneumoniae pneumonia.
@en
type
label
Proton pump inhibitor therapy ...... tococcus pneumoniae pneumonia.
@en
prefLabel
Proton pump inhibitor therapy ...... tococcus pneumoniae pneumonia.
@en
P2093
P2860
P356
P1476
Proton pump inhibitor therapy ...... tococcus pneumoniae pneumonia.
@en
P2093
A B van Gageldonk-Lafeber
C P C de Jager
E F A Gemen
G C M Kusters
M G H van Oijen
P D Siersema
R J F Laheij
P2860
P304
P356
10.1111/APT.12069
P407
P577
2012-10-03T00:00:00Z